93 related articles for article (PubMed ID: 10381366)
1. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus.
Ciotti M; Basu N; Brangi M; Owens IS
Biochem Biophys Res Commun; 1999 Jun; 260(1):199-202. PubMed ID: 10381366
[TBL] [Abstract][Full Text] [Related]
2. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).
Gagné JF; Montminy V; Belanger P; Journault K; Gaucher G; Guillemette C
Mol Pharmacol; 2002 Sep; 62(3):608-17. PubMed ID: 12181437
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.
Jinno H; Tanaka-Kagawa T; Hanioka N; Saeki M; Ishida S; Nishimura T; Ando M; Saito Y; Ozawa S; Sawada J
Drug Metab Dispos; 2003 Jan; 31(1):108-13. PubMed ID: 12485959
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.
Jinno H; Saeki M; Saito Y; Tanaka-Kagawa T; Hanioka N; Sai K; Kaniwa N; Ando M; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Ozawa S; Sawada J
J Pharmacol Exp Ther; 2003 Aug; 306(2):688-93. PubMed ID: 12730278
[TBL] [Abstract][Full Text] [Related]
5. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.
Villeneuve L; Girard H; Fortier LC; Gagné JF; Guillemette C
J Pharmacol Exp Ther; 2003 Oct; 307(1):117-28. PubMed ID: 12944498
[TBL] [Abstract][Full Text] [Related]
6. Effects of common genetic variants of human uridine diphosphate glucuronosyltransferase subfamilies on irinotecan glucuronidation.
Tagawa K; Maruo Y; Mimura Y; Ikushiro S
Toxicol Mech Methods; 2023 Mar; 33(3):197-205. PubMed ID: 35930428
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
[TBL] [Abstract][Full Text] [Related]
8. A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
Cai H; Nguyen N; Peterkin V; Yang YS; Hotz K; La Placa DB; Chen S; Tukey RH; Stevens JC
Drug Metab Dispos; 2010 May; 38(5):879-86. PubMed ID: 20124398
[TBL] [Abstract][Full Text] [Related]
9. UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers.
Oguri T; Takahashi T; Miyazaki M; Isobe T; Kohno N; Mackenzie PI; Fujiwara Y
Anticancer Res; 2004; 24(5A):2893-6. PubMed ID: 15517893
[TBL] [Abstract][Full Text] [Related]
10. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.
Basu NK; Kubota S; Meselhy MR; Ciotti M; Chowdhury B; Hartori M; Owens IS
J Biol Chem; 2004 Jul; 279(27):28320-9. PubMed ID: 15117964
[TBL] [Abstract][Full Text] [Related]
13. Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in Japanese.
Saito Y; Sai K; Maekawa K; Kaniwa N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Ohtsu A; Matsumura Y; Saijo N; Sawada J
Drug Metab Dispos; 2009 Feb; 37(2):272-6. PubMed ID: 18981166
[TBL] [Abstract][Full Text] [Related]
14. Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11).
Chen S; Yueh MF; Bigo C; Barbier O; Wang K; Karin M; Nguyen N; Tukey RH
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19143-8. PubMed ID: 24191041
[TBL] [Abstract][Full Text] [Related]
15. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice.
Mallick P; Shah P; Gandhi A; Ghose R
Life Sci; 2015 Oct; 139():132-8. PubMed ID: 26334566
[TBL] [Abstract][Full Text] [Related]
16. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes.
Hanioka N; Tanabe N; Jinno H; Tanaka-Kagawa T; Nagaoka K; Naito S; Koeda A; Narimatsu S
Life Sci; 2010 Aug; 87(7-8):261-8. PubMed ID: 20620155
[TBL] [Abstract][Full Text] [Related]
18. The contribution of intestinal UDP-glucuronosyltransferases in modulating 7-ethyl-10-hydroxy-camptothecin (SN-38)-induced gastrointestinal toxicity in rats.
Tallman MN; Miles KK; Kessler FK; Nielsen JN; Tian X; Ritter JK; Smith PC
J Pharmacol Exp Ther; 2007 Jan; 320(1):29-37. PubMed ID: 17003228
[TBL] [Abstract][Full Text] [Related]
19. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
[TBL] [Abstract][Full Text] [Related]
20. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
